Former orphan TLX becomes unique for its effects while triple-negative falling into its nuclear nets
Medicomunicare Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have discovered that the nuclear receptor TLX can potentially be used for therapeutic intervention. Researchers have been…
Read more